Page last updated: 2024-10-31

metyrapone and Carbohydrate Metabolism, Inborn Error

metyrapone has been researched along with Carbohydrate Metabolism, Inborn Error in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wannarachue, N1
Ruvalcaba, RH1
Tolis, G1
Lewis, W1
Verdy, M1
Friesen, HG1
Solomon, S1
Pagalis, G1
Pavlatos, F1
Fessas, P1
Rochefort, JG1

Other Studies

2 other studies available for metyrapone and Carbohydrate Metabolism, Inborn Error

ArticleYear
Hypogonadism in Prader-Willi syndrome.
    American journal of mental deficiency, 1975, Volume: 79, Issue:5

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Carbohyd

1975
Anterior pituitary function in the Prader-Labhart-Willi (PLW) syndrome.
    The Journal of clinical endocrinology and metabolism, 1974, Volume: 39, Issue:6

    Topics: 17-Ketosteroids; Adolescent; Adult; Carbohydrate Metabolism, Inborn Errors; Chorionic Gonadotropin;

1974